全球產前篩檢市場－市場規模（按細分市場分類）、佔有率、監管、報銷及預測（至2036年）

本報告對全球產前篩檢市場進行了深入分析，提供了各地區的市場規模、主要趨勢、創新產品和技術以及競爭格局等資訊。

市場模式的主要組成如下：

市售產前篩檢及不斷變化的競爭格局

• 主要產業趨勢分析
• 產前篩檢市場各細分領域的年度收入和市場展望（2015-2036 年）
• 市場層級的數據，包括數量、平均售價和市場價值。

全球、區域和國家層面的市場考察。

• 這提供了按地區分類的定性市場資訊，以及市場考察。
• 產前篩檢市場的SWOT分析
• 產前篩檢市場競爭動態分析及趨勢

了解整體情況，包括對醫療保健系統的概覽，有助於理解市場。此外，市場准入部分提供有關報銷政策和監管環境的資訊，從而可以更深入地探索市場動態。

• 各國醫療保健系統概覽
• 各國還款政策
• 各國醫療科技監管狀況

目標公司

• Illumina Inc
• BGI Genomics Co Ltd
• Yourgene Health Plc
• Eurofins Scientific SE
• Agilent Technologies Inc
• Roche Diagnostics International Ltd
• Revvity Inc
• Beckman Coulter Inc
• Abbott Laboratories
• Siemens Healthineers AG
• Quidel Corp
• Thermo Fisher Scientific Inc
• Tosoh Corp
• 其他

Prenatal Screening Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area.

Prenatal screening describes tests that detect potential problems that affect the viability and development of the fetus using both less invasive and more invasive sampling techniques. Prenatal Screening is now routinely used in developed countries for early detection of chromosomal abnormalities and NTDs.In most countries, maternal serum screening and ultrasound remain standard-of-care for screening of pregnant women for chromosome aneuploidies and other birth defects.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Prenatal Screening and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Prenatal Screening market revenue by segment and market outlooks from 2015-2036.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Prenatal Screening market.
• Competitive dynamics insights and trends provided for Prenatal Screening market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Illumina Inc, BGI Genomics Co Ltd, Yourgene Health Plc, Eurofins Scientific SE, Agilent Technologies Inc, Roche Diagnostics International Ltd, Revvity Inc, Beckman Coulter Inc, Abbott Laboratories, Siemens Healthineers AG, Quidel Corp, Thermo Fisher Scientific Inc, Tosoh Corp, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Prenatal Screening market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Prenatal Screening market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Prenatal Screening market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Prenatal Screening market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.